Gastroenterology
Volume 137, Issue 6 , Pages 1976-1985.e10 , December 2009

Expanded Extracolonic Tumor Spectrum in MUTYH-Associated Polyposis

  • Stefanie Vogt

      Affiliations

    • Institute of Human Genetics, University of Bonn, Bonn, Germany
  • ,
  • Natalie Jones

      Affiliations

    • Institute of Medical Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff, UK
  • ,
  • Daria Christian

      Affiliations

    • Institute of Human Genetics, University of Bonn, Bonn, Germany
  • ,
  • Christoph Engel

      Affiliations

    • Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany
  • ,
  • Maartje Nielsen

      Affiliations

    • Centre for Human and Clinical Genetics, LUMC, Leiden, The Netherlands
  • ,
  • Astrid Kaufmann

      Affiliations

    • Institute of Human Genetics, University of Bonn, Bonn, Germany
  • ,
  • Verena Steinke

      Affiliations

    • Institute of Human Genetics, University of Bonn, Bonn, Germany
  • ,
  • Hans F. Vasen

      Affiliations

    • Department of Gastroenterology and Hepatology, LUMC, Leiden, The Netherlands
  • ,
  • Peter Propping

      Affiliations

    • Institute of Human Genetics, University of Bonn, Bonn, Germany
  • ,
  • Julian R. Sampson

      Affiliations

    • Institute of Medical Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff, UK
  • ,
  • Frederik J. Hes

      Affiliations

    • Centre for Human and Clinical Genetics, LUMC, Leiden, The Netherlands
  • ,
  • Stefan Aretz

      Affiliations

    • Institute of Human Genetics, University of Bonn, Bonn, Germany
    • Corresponding Author InformationReprint requests Address requests for reprints to: Stefan Aretz, MD, Institute of Human Genetics, University of Bonn, Wilhelmstrasse 31, D-53111 Bonn, Germany. fax: +49-(0)228-287-22380

Received 14 April 2009 ,Accepted 18 August 2009.

References 

  1. Al-Tassan N, Chmiel NH, Maynard J, et al. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat Genet. 2002;30:227–232
  2. Sieber OM, Lipton L, Crabtree M, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med. 2003;348:791–799
  3. Sampson JR, Dolwani S, Jones S, et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet. 2003;362:39–41
  4. Fleischmann C, Peto J, Cheadle J, et al. Comprehensive analysis of the contribution of germline MYH variation to early-onset colorectal cancer. Int J Cancer. 2004;109:554–558
  5. Aretz S, Uhlhaas S, Goergens H, et al. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer. 2006;119:807–814
  6. Gismondi V, Meta M, Bonelli L, et al. Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. Int J Cancer. 2004;109:680–684
  7. Isidro G, Laranjeira F, Pires A, et al. Germline MUTYH (MYH) mutations in Portuguese individuals with multiple colorectal adenomas. Hum Mutat. 2004;24:353–354
  8. Wang L, Baudhuin LM, Boardman LA, et al. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology. 2004;127:9–16
  9. Eliason K, Hendrickson BC, Judkins T, et al. The potential for increased clinical sensitivity in genetic testing for polyposis colorectal cancer through the analysis of MYH mutations in North American patients. J Med Genet. 2005;42:95–96
  10. Venesio T, Molatore S, Cattaneo F, et al. High frequency of MYH gene mutations in a subset of patients with familial adenomatous polyposis. Gastroenterology. 2004;126:1681–1685
  11. Kairupan CF, Meldrum CJ, Crooks R, et al. Mutation analysis of the MYH gene in an Australian series of colorectal polyposis patients with or without germline APC mutations. Int J Cancer. 2005;116:73–77
  12. Nielsen M, Franken PF, Reinards TH, et al. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet. 2005;42:e54
  13. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol. 2006;101:385–398
  14. Farrington SM, Tenesa A, Barnetson R, et al. Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet. 2005;77:112–119
  15. Nielsen M, Joerink-van de Beld MC, Jones N, et al. Analysis of MUTYH genotypes and colorectal phenotypes in patients with MUTYH-associated polyposis. Gastroenterology. 2009;136:471–476
  16. Ponti G, Ponz de Leon M, Maffei S, et al. Attenuated familial adenomatous polyposis and Muir–Torre syndrome linked to compound biallelic constitutional MYH gene mutations. Clin Genet. 2005;68:442–447
  17. Baglioni S, Melean G, Gensini F, et al. A kindred with MYH-associated polyposis and pilomatricomas. Am J Med Genet A. 2005;134:212–214
  18. Buecher B, Baert-Desurmont S, Leborgne J, et al. Duodenal adenocarcinoma and Mut Y human homologue-associated polyposis. Eur J Gastroenterol Hepatol. 2008;20:1024–1027
  19. Jones S, Emmerson P, Maynard J, et al. Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C→T:A mutations. Hum Mol Genet. 2002;11:2961–2967
  20. Nielsen M, Poley JW, Verhoef S, et al. Duodenal carcinoma in MUTYH-associated polyposis. J Clin Pathol. 2006;59:1212–1215
  21. Kanter-Smoler G, Bjork J, Fritzell K, et al. Novel findings in Swedish patients with MYH-associated polyposis: mutation detection and clinical characterization. Clin Gastroenterol Hepatol. 2006;4:499–506
  22. Offerhaus GJ, Entius MM, Giardiello FM. Upper gastrointestinal polyps in familial adenomatous polyposis. Hepatogastroenterology. 1999;46:667–669
  23. Burt RW. Gastric fundic gland polyps. Gastroenterology. 2003;125:1462–1469
  24. Kadmon M, Tandara A, Herfarth C. Duodenal adenomatosis in familial adenomatous polyposis coli (A review of the literature and results from the Heidelberg Polyposis Register). Int J Colorectal Dis. 2001;16:63–75
  25. Bülow S, Bjork J, Christensen IJ, et al. Duodenal adenomatosis in familial adenomatous polyposis. Gut. 2004;53:381–386
  26. Kim CJ, Cho YG, Park CH, et al. Genetic alterations of the MYH gene in gastric cancer. Oncogene. 2004;23:6820–6822
  27. Wallace MH, Phillips RK. Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg. 1998;85:742–750
  28. Offerhaus GJ, Giardiello FM, Krush AJ, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology. 1992;102:1980–1982
  29. Vasen HF, Bulow S, Myrhoj T, et al. Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis. Gut. 1997;40:716–719
  30. Aarnio M, Sankila R, Pukkala E, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer. 1999;81:214–218
  31. Sijmons RH, Kiemeney LA, Witjes JA, et al. Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options. J Urol. 1998;160:466–470
  32. Vasen HF, Stormorken A, Menko FH, et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol. 2001;19:4074–4080
  33. Myrhoj T, Andersen MB, Bernstein I. Screening for urinary tract cancer with urine cytology in Lynch syndrome and familial colorectal cancer. Fam Cancer. 2008;7:303–307
  34. Sieber OM, Howarth KM, Thirlwell C, et al. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice. Cancer Res. 2004;64:8876–8881
  35. Le Page F, Randrianarison V, Marot D, et al. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. Cancer Res. 2000;60:5548–5552
  36. Beiner ME, Zhang WW, Zhang S, et al. Mutations of the MYH gene do not substantially contribute to the risk of breast cancer. Breast Cancer Res Treat. 2009;114:575–578
  37. Barnetson RA, Devlin L, Miller J, et al. Germline mutation prevalence in the base excision repair gene, MYH, in patients with endometrial cancer. Clin Genet. 2007;72:551–555
  38. Tricarico R, Bet P, Ciambotti B, et al. Endometrial cancer and somatic G>T KRAS transversion in patients with constitutional MUTYH biallelic mutations. Cancer Lett. 2009;274:266–270
  39. Campbell WJ, Spence RA, Parks TG. The role of congenital hypertrophy of the retinal pigment epithelium in screening for familial adenomatous polyposis. Int J Colorectal Dis. 1994;9:191–196
  40. Giardiello FM, Petersen GM, Piantadosi S, et al. APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis. Gut. 1997;40:521–525
  41. Mangold E, Pagenstecher C, Leister M, et al. A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir–Torre syndrome. J Med Genet. 2004;41:567–572
  42. South CD, Hampel H, Comeras I, et al. The frequency of Muir–Torre syndrome among Lynch syndrome families. J Natl Cancer Inst. 2008;100:277–281
  43. Entius MM, Keller JJ, Drillenburg P, et al. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir–Torre syndrome. Clin Cancer Res. 2000;6:1784–1789
  44. Kruse R, Rutten A, Lamberti C, et al. Muir–Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet. 1998;63:63–70
  45. Ajith Kumar VK, Gold JA, Mallon E, et al. Sebaceous adenomas in an MYH associated polyposis patient of Indian (Gujarati) origin. Fam Cancer. 2008;7:187–189
  46. Heinimann K, Mullhaupt B, Weber W, et al. Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status. Gut. 1998;43:675–679
  47. Pujol RM, Casanova JM, Egido R, et al. Multiple familial pilomatricomas: a cutaneous marker for Gardner syndrome?. Pediatr Dermatol. 1995;12:331–335
  48. Urabe K, Xia J, Masuda T, et al. Pilomatricoma-like changes in the epidermoid cysts of Gardner syndrome with an APC gene mutation. J Dermatol. 2004;31:255–257
  49. Chuang CC, Lin HC. Pilomatrixoma of the head and neck. J Chin Med Assoc. 2004;67:633–636
  50. Kairupan C, Scott RJ. Base excision repair and the role of MUTYH. Hered Cancer Clin Pract. 2007;5:199–209
  51. Mazurek A, Berardini M, Fishel R. Activation of human MutS homologs by 8-oxo-guanine DNA damage. J Biol Chem. 2002;277:8260–8266
  52. Gu Y, Parker A, Wilson TM, et al. Human MutY homolog, a DNA glycosylase involved in base excision repair, physically and functionally interacts with mismatch repair proteins human MutS homolog 2/human MutS homolog 6. J Biol Chem. 2002;277:11135–11142
  53. Russo MT, De Luca G, Degan P, et al. Different DNA repair strategies to combat the threat from 8-oxoguanine. Mutat Res. 2007;614:69–76
  54. Giardiello FM, Offerhaus GJ, Lee DH, et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut. 1993;34:1394–1396
  55. Goecke T, Schulmann K, Engel C, et al. Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol. 2006;24:4285–4292
  56. Vasen HF, Moslein G, Alonso A, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut. 2008;57:704–713
  57. Albert USH. Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland. 1. Aktualisierung. Wien, New York: W. Zuckschwerdt Verlag München; 2008;http://leitlinien.netAccessed February 2008
  58. Perry N, Broeders M, de Wolf C, et al. European Guidelines for quality assurance in breast cancer screening and diagnosis. In: 4th ed.. Luxembourg: Office for Official Publications of the European Communities; 2006;
  59. Otto SJ, Fracheboud J, Looman CW, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet. 2003;361:1411–1417
  60. Dove-Edwin I, Boks D, Goff S, et al. The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma. Cancer. 2002;94:1708–1712
  61. Bastacky S, Ibrahim S, Wilczynski SP, et al. The accuracy of urinary cytology in daily practice. Cancer. 1999;87:118–128

 Conflicts of interest The authors disclose no conflicts.

 Funding The study was supported by the German Cancer Aid (Deutsche Krebshilfe e.V. Bonn, grant no. 106244), part funded by Cancer Research Wales, the Wales Office of Research and Development through the Wales Gene Park, and the Dutch Digestive Diseases Foundation (grant no. MWO 0355).

PII: S0016-5085(09)01510-8

doi: 10.1053/j.gastro.2009.08.052

Gastroenterology
Volume 137, Issue 6 , Pages 1976-1985.e10 , December 2009